
     RDKit          2D

 12 11  0  0  0  0  0  0  0  0999 V2000
   -0.0015   -0.2065    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7128    0.2059    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7160    0.2059    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4305   -0.2065    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1449    0.2059    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8594   -0.2065    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1449    1.0309    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4273   -0.2065    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1418    0.2059    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4273   -1.0315    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8595   -0.2059    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1451    1.0315    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  2  8  1  0
  3  4  1  0
  4  5  1  0
  5  7  2  0
  5  6  1  0
  8  9  1  0
  8 10  1  1
  9 11  1  0
  9 12  2  0
M  END
>  <DRUGBANK_ID>  (1) 
DB01833

>  <SECONDARY_ACCESSION_NUMBERS>  (1) 
EXPT01587

>  <COMMON_NAME>  (1) 
Canavanine

>  <CAS_NUMBER>  (1) 
543-38-4

>  <UNII>  (1) 
3HZV514J4B

>  <SYNONYMS>  (1) 
(L)-Canavanine; 2-Amino-4-(guanidinooxy)butyric acid; Canavanin; L-Canavanine; O-((Aminoiminomethyl)amino)-L-homoserine

$$$$
